Skip to content
TrialMatch
Sign up
Recruiting

Evaluating Efficacy and Tolerability of Anticancer Drug Therapies for the Treatment of Gynecologic and Breast Cancers

Create a profile to match View the full record on ClinicalTrials.gov

About this study

retrospective/prospective observational study. Objective of the study is to evaluate the effect of drugs in terms of objective responses, disease-free survival (DFS), progression-free survival (PFS), overall survival (OS), and side effects compared with registry studies in the medical therapy of breast and gynecologic cancers.

Condition
Breast Cancer Early Stage Breast Cancer (Stage 1-3), Breast Cancer Metastatic, Ovarian Cancer, Cervical Carcinoma, Endometrial Cancer
Tested
Oncologic drugs administered for treatment of breast cancer, Oncologic drug administered for treatment of gynecologic ca...
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna

Who can join

Age
18 years and older
Sex
All sexes
Healthy volunteers
Not accepted

Inclusion 5

  • Minimum age: 18 years
  • Study condition: Breast Cancer Early Stage Breast Cancer (Stage 1-3), Breast Cancer Metastatic, Ovarian Cancer, Cervical Carcinoma, Endometrial Cancer
  • Diagnosis of histologically confirmed breast cancer or gynecological cancer, either early stage or metastatic;
  • Patients who have received treatment for breast cancer or gynecologic cancer since January 2010;
  • Any patient currently living and actually contactable must sign an informed consent to the study and processing of personal data.

Exclusion 1

  • no exclusion criteria

Where

1 site, 1 recruiting

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Bologna, Italy

Recruiting

Contact

Potential match only. Final eligibility is determined by the study team.